Jose Miguel
Rivera Caravaca
Profesor Permanente Laboral
University of Liverpool
Liverpool, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Liverpool (31)
2024
-
Impact of prior oral anticoagulation therapies on post-discharge outcomes after COVID-19: Results from a global federated health network analysis
European Journal of Clinical Investigation
-
Navigating the bleeding risk dilemma in patients with atrial fibrillation on therapy with direct-acting oral anticoagulants: Comparing the HAS-BLED vs. DOAC Score
European Journal of Internal Medicine
-
Patients with atrial fibrillation and common exclusion criteria from clinical trials are at high risk of clinical events: the Murcia AF Project II (MAFP-II) cohort study
Internal and Emergency Medicine, Vol. 19, Núm. 7, pp. 1941-1948
2023
-
Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis
Journal of Clinical Medicine, Vol. 12, Núm. 8
-
Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis
Clinical Cardiology, Vol. 46, Núm. 6, pp. 656-662
-
Epilepsy-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications in patients with Epilepsy
Current Problems in Cardiology, Vol. 48, Núm. 10
-
Ibrutinib use and adverse cardiovascular outcomes: A United States federated electronic medical records analysis
European Journal of Internal Medicine
-
Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making
American Heart Journal, Vol. 258, pp. 1-16
-
Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review
Science of the Total Environment, Vol. 880
-
Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
Biomedicine and Pharmacotherapy, Vol. 158
-
Response to letter from Du et al. regarding article ‘Sodium-glucose cotransporter-2 inhibitor use was associated with lower risks of stroke and cardiac arrest but not ventricular arrhythmias?’
Diabetes, Obesity and Metabolism
-
Simplified Geleijnse score for identifying chest pain features associated with coronary ischemia
Heart and Lung, Vol. 59, pp. 61-66
-
Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis
Internal and Emergency Medicine, Vol. 18, Núm. 2, pp. 423-428
2022
-
Adherence to the 'Atrial Fibrillation Better Care' Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients
Thrombosis and Haemostasis, Vol. 122, Núm. 3, pp. 406-414
-
Anthropometric Measures and Risk of Cardiovascular Disease: Is there an Opportunity for Non-Traditional Anthropometric Assessment? A Review
Reviews in Cardiovascular Medicine, Vol. 23, Núm. 12
-
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry
International Journal of Clinical Practice, Vol. 2022
-
Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system
Frontiers in Cardiovascular Medicine
-
Growth Differentiation Factor 15 in Cardiovascular Diseases: Predicting Bleeding after Cardiac Surgery and beyond That!
Thrombosis and Haemostasis, Vol. 122, Núm. 5, pp. 657-660
-
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry
European heart journal. Cardiovascular pharmacotherapy, Vol. 9, Núm. 1, pp. 38-46
2021
-
Cardiovascular risk factors, cardiovascular disease, and COVID-19: An umbrella review of systematic reviews
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 7, Núm. 4, pp. 330-339